Welcome to Guangzhou IGE Biotechnology Co., Ltd. Website !
Main Page > Services > Next-generation sequencing > Olink


未标题-2

        Proteomics is the study of proteins, which are the basic units of life that perform the functions of life. Compared to genomics, proteomics has a closer and more direct relationship with disease. This is because RNA expression levels are not highly correlated with protein expression levels, especially for low-abundance proteins. Additionally, 90% of drug targets and biomarkers used in clinical applications are proteins. Therefore, even though the development of nucleic acid levels has reached a fever pitch, the detection of proteomics is still very necessary.


        IGEBio has launched the Olink targeted proteomics product, which can accurately detect body fluid samples, including low-abundance proteins.

1

        Olink proteomics uses the proximity extension assay (PEA) technology, which combines the high specificity of antibody-based immunoassays and the high-throughput and high-sensitivity of genomics. It plays an important role in precision proteomics research and provides a new choice for multi-omics research. It has also been recommended by the Human Protein Atlas website as one of the three detection methods.

2

图1:THE HUMAN PROTEIN ATLAS/BLOOD PROTEIN



产品分类

96 Panel series:

14 human panels (7 major diseases, 7 biological pathways) + 1 mouse panel

3

384~3072 panel  series:

Explore 384 Cardiometabolic

Explore 384 Neurology

Explore 384 Inflammation

Explore 384 Oncology

Olink Explore 1536

Olink Explore 3072


Researchers can choose the corresponding panel according to their research direction and disease type to complete targeted proteomics detection.



Experimental process

48/96panel series(qPCR)

4

Explore series(NGS)

5


PEA overcomes the technical challenges in proteomics

6


        High specificity: Each target protein is recognized by two adjacent antibodies, and each protein is also labeled with a barcode.


        High throughput: Rapidly detect 48-3072 target protein biomarkers in batch samples.


        High sensitivity and wide detection range: The detection sensitivity can cover 10 logs, down to the fg/ml level, and cover proteins of different abundances, especially low-abundance inflammatory factors or cytokines.


        More economical: A large number of target proteins can be equipped with the NGS platform to complete the detection economically and efficiently.


        Low sample volume: Each sample requires only 1-6 ul, and 6 ul of sample can detect 3000 proteins.


        Targeted: All detected proteins are biomarkers and cover 100% of signaling pathways (supported by top institutions and experts worldwide).


        Multi-omics: It can be connected to NGS and qPCR platforms to produce data, and the flexible data model can be combined with multi-omics joint analysis.


7

图2 Olink PEA 技术原理


截至2022年2月份全球累计的发文情况


8




部分应用该技术的文章

9

10

11

12

13


        Protein types

        Secreted proteins

        Organ-specific proteins

        Inflammatory factors

        Cytokines

        Drug target marker screening

        New proteins discovered by mass spectrometry


        Sample types

        Serum

        Various plasmas

        Tissue lysates

        Cell culture medium

        Cerebrospinal fluid

        Urine

        Cell lysates

        Microbubbles/exosomes

        Tissue fluid

        Dialysis fluid

        Fine-needle biopsy tissue samples

        Dried blood spots

        Synovial fluid

        Saliva

        Eye aqueous humor (human)



Applications

Targeted proteomics research in the scientific research field

Development of liquid biopsy diagnostic markers such as body fluids/exosomes

Discovery of biomarkers in the drug development process

Clinical basic research

Medical transformation

Multi-omics joint application development




Case studies

Case 1

14

15



Case 2

16

17


Case 3

18

19


Case 4

20

21


Case 5

22

23






 




HotServices
020-89053723
Guangzhou IGE Biotechnology Co., Ltd.
Email: marketing@igebio.com
QQ: 1787730693
Address: Building G1-903, South China New Materials Innovation Park, #31 Kefeng Road, Huangpu Dist. Guangzhou, Guangdong prov. China 510663

Copyright © Guangzhou IGE Biotechnology Co., Ltd. 粤ICP备2021146096号
Contact Us
  • Contact Us